CandlesenseCandlesense
VCYTClinical Trials•businesswire•

Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

Sentiment:Positive (70)

Summary

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--Veracyte Announces New Study in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 27, 2025 by businesswire

← Back to VCYT News
    Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer | VCYT Stock News | Candlesense